Back to Journals » Vascular Health and Risk Management
Vascular Health and Risk Management
Editor-in-Chief: Professor Roland Asmar
ISSN 1176-6344 (Print) - went to online only in 2009
Vascular Health and Risk Management is an international, peer-reviewed open access journal focusing on the maintenance of vascular health, disease prevention, risk factors, therapeutics, monitoring and risk management of vascular disease and its sequelae. The journal also seeks to address the association between lifestyle, hypertension, vascular biology, metabolic syndrome, obesity and vascular health & disease. The journal will consider studies on drugs, drug design and development, and therapeutic use.
The journal welcomes original research, clinical and epidemiological studies, reviews and evaluations, guidelines, expert opinion and commentary.
Official journal of the International Society of Vascular Health (ISVH)
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
We are currently seeking expressions of interest for an Associate Editor position on this journal.
Please send your CV and a one-page vision statement detailing your overall objectives for the journal to Karen Benskin ([email protected]).
Articles:
- View all (1700)
- Volume 22, 2026 (61)
- Volume 21, 2025 (89)
- Volume 20, 2024 (54)
- Volume 19, 2023 (86)
- Volume 18, 2022 (87)
- Volume 17, 2021 (80)
- Volume 16, 2020 (60)
- Volume 15, 2019 (54)
- Volume 14, 2018 (42)
- Volume 13, 2017 (54)
- Volume 12, 2016 (52)
- Volume 11, 2015 (66)
- Volume 10, 2014 (74)
- Volume 9, 2013 (73)
- Volume 8, 2012 (74)
- Volume 7, 2011 (92)
- Volume 6, 2010 (113)
- Volume 5, 2009 (112)
- Volume 4, 2008 (164)
- Volume 3, 2007 (113)
- Volume 2, 2006 (57)
- Volume 1, 2005 (43)
Latest articles:
- 5 records -
Comparison of FINDRISC and the Framingham Model for Predicting CHD Risk: Results from the Kharameh Cohort Study
Hamedi A, Seif M, Sharifi MH, Rezaianzadeh A, Lashkardoost H, Baberi F, Hassanzadeh J
Vascular Health and Risk Management 2026, 22:619033
Published Date: 14 July 2026
Explainable Machine Learning for Risk Prediction of Reduced Quality of Life in Hypertension
Andala S, Iqhrammullah M, Agusri A, De Liyis BG, Rampengan DD, Rampengan SH, Fahdhienie F, Habiburrahman M
Vascular Health and Risk Management 2026, 22:614061
Published Date: 14 July 2026
Elevated Hydrocarbon Exposure Escalates Coronary and Cerebrovascular Disease Risks: A Comprehensive Systematic Review
Sulthana H, Kasoj M, Kumar S, Jan A, Dubwa D
Vascular Health and Risk Management 2026, 22:607849
Published Date: 10 July 2026
Five-Year Outcomes of Paclitaxel-Coated Balloons in Patients with Diabetes from the BIOLUX P-III Single-Arm Study
Dodd J, Stratford G, Brodmann M, Moscovic M, Wang JCC, Nano G, Zeller T, Christensen JK, Tepe G, Mwipatayi BP
Vascular Health and Risk Management 2026, 22:595482
Published Date: 30 June 2026
Drug-Coated Balloon Angioplasty for de Novo Subclavian Artery Stenosis: Mid-Term Outcomes and Independent Risk Factors for Restenosis
Zhang X, Wang Y, Tang H, Li D
Vascular Health and Risk Management 2026, 22:611561
Published Date: 29 June 2026